Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant Gliomas

Background. No established chemotherapeutic regimen exists for the treatment of recurrent malignant gliomas (rMGs). Herein, we report the activity and safety results of the bevacizumab (B) plus fotemustine (FTM) combination for the treatment of rMGs. Patients and Methods. An induction phase consiste...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Vaccaro, V., Fabi, A., Vidiri, A., Giannarelli, D., Metro, G., Telera, S., Vari, S., Piludu, F., Carosi, M. A., Villani, V., Cognetti, F., Pompili, A., Marucci, L., Carapella, C. M., Pace, A.
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi Publishing Corporation 2014
Fag:
Clinical Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4024398/
https://ncbi.nlm.nih.gov/pubmed/24877084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/351252
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker